Cargando…
Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy
BACKGROUND: Fabry disease is a treatable X-linked condition leading to progressive cardiomyopathy, arrhythmia and premature death. Atrial and ventricular arrhythmias contribute significantly to adverse prognosis; however, guidance to determine which patients require cardiovascular implantable electr...
Autores principales: | Vijapurapu, Ravi, Geberhiwot, Tarekegn, Jovanovic, Ana, Baig, Shanat, Nordin, Sabrina, Kozor, Rebecca, Leyva, Francisco, Kotecha, Dipak, Wheeldon, Nigel, Deegan, Patrick, Rusk, Rosemary A, Moon, James C, Hughes, Derralynn A, Woolfson, Peter, Steeds, Richard P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900228/ https://www.ncbi.nlm.nih.gov/pubmed/31446426 http://dx.doi.org/10.1136/heartjnl-2019-315229 |
Ejemplares similares
-
Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease
por: Vijapurapu, Ravi, et al.
Publicado: (2023) -
A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice
por: Vijapurapu, Ravi, et al.
Publicado: (2019) -
Quality of life and healthcare utilisation improvements after atrial fibrillation ablation
por: Gupta, Dhiraj, et al.
Publicado: (2021) -
Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis
por: Gill, Simrat, et al.
Publicado: (2022) -
Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
por: Vijapurapu, Ravi, et al.
Publicado: (2022)